IncellDx, Inc. Announces a Supply Agreement with Accuri to Offer Complete Solution for Cervical Cancer Screening

MENLO PARK, Calif.--(BUSINESS WIRE)--IncellDx, Inc. today announced a supply agreement with Accuri Cytometers, Inc. that combines new patented technology from IncellDx with the unique capabilities available from the Accuri C6 Flow Cytometer® technology.
MORE ON THIS TOPIC